Second Lawsuit from Pfizer to Novo Nordisk!

Pfizer, Novo Nordisk, and the biotechnology company Metsera have filed a second lawsuit against them. This lawsuit has been submitted to block Novo Nordisk's attempt to acquire Metsera. By initiating this legal action, Pfizer claims that there have been actions against competition in the biotechnology sector.

Such legal processes in the biotechnology market stand out as developments that investors should closely monitor. Pfizer's move could change the dynamics in the sector and affect market trends.